Roche boosts forecast for 2013 on promise of expected breast cancer drug
The world’s biggest maker of oncology treatments has applied for regulatory approval of T-DM1, a breast cancer medicine that the FDA will rule on late next month
Go here to read the rest:
Roche boosts forecast for 2013 on promise of expected breast cancer drug
Leave a Reply
You must be logged in to post a comment.
View video inside